Trials / Withdrawn
WithdrawnNCT02106871
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Phase I Assessment of NO Mediated Signaling in Cancer Cachexia
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.
Detailed description
This is a double-blinded, placebo-controlled trial in men and women, 40-75 years old, diagnosed with pancreatic or cholangiocarcinoma cancer. Patients will receive placebo or sildenafil daily for 4 weeks during their initial chemotherapy cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | 50mg of Sildenafil daily for 4 weeks |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2014-04-08
- Last updated
- 2017-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02106871. Inclusion in this directory is not an endorsement.